Updated role of nitric oxide in disorders of erythrocyte function

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 13, Issue 1, 2013, Pages 83-87

  Kahn, Marc J ^a   Maley, Jason H ^a   Lasker, George F ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Banked blood; Erythrocytes; Hemoglobin; Nitric oxide; Nitrite reductase; Sickle cell disease

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C5; DECAY ACCELERATING FACTOR; DEOXYHEMOGLOBIN; ECULIZUMAB; HEMOGLOBIN; MYOGLOBIN; NITRIC OXIDE; NITRITE REDUCTASE; SILDENAFIL;

BLOOD TRANSFUSION; ERYTHROCYTE DISORDER; HUMAN; MULTICENTER STUDY (TOPIC); NONHUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SICKLE CELL ANEMIA;

ANIMALS; CLINICAL TRIALS, PHASE II AS TOPIC; ERYTHROCYTES; HEMATOLOGIC DISEASES; HEMOGLOBINS; HUMANS; NITRIC OXIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84876696470     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X11313010009     Document Type: Review

References (45)

1. Maley, J.H.; Lasker, G.F.; Kadowitz, P.J. Nitric oxide and disorders of the erythrocyte: emerging roles and therapeutic targets. Cardiovasc. Hematol. Disord. Drug Targets, 2010, 10(4), 284-291.
2. Jia, L.; Bonaventura, C.; Bonaventura, J.; Stamler, J.S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature, 1996, 380(6571), 221-226.
3. Gladwin, M.T.; Kim-Shapiro, D.B. The functional nitrite reductase activity of the heme-globins. Blood, 2008, 112(7), 2636-2647.
4. Totzeck, M.; Hendgen-Cotta, U.B.; Luedike, P.; Berenbrink, M.; Klare, J.P.; Steinhoff, H J.; Semmler, D.; Shiva, S.; Williams, D.; Kipar, A.; Gladwin, M.T.; Schrader, J.; Kelm, M.; Cossins, A.R.; Rassaf, T. Nitrite Regulates Hypoxic Vasodilation via Myoglobin-Dependent Nitric Oxide Generation. Circulation, 2012, 126(3), 325-334.
5. Banerjee, T.; Kuypers, F.A. Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. B r. J. Haematol., 2004, 124(3), 391-402.
6. Wandersee, N.J.; Tait, J.F.; Barker, J.E. Erythroid phosphatidyl serine exposure is not predictive of thrombotic risk in mice with hemolytic anemia. Blood Cells Mol. Dis., 2000, 26(1), 75-83.
7. Wood, K.C.; Hsu, L.L.; Gladwin, M. T. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic. Biol. Med., 2008, 44(8), 1506-1528.
8. Deonikar, P.; Kavdia, M. Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis. J. Appl. Physiol., 2012, 112(8), 1383-1392.
9. Gladwin, M.T.; Kato, G.J.; Weiner, D.; Onyekwere, O.C.; Dampier, C.; Hsu, L.; Hagar, R.W.; Howard, T.; Nuss, R.; Okam, M.M.; Tremonti, C.K.; Berman, B.; Villella, A.; Krishnamurti, L.; Lanzkron, S.; Castro, O.; Gordeuk, V.R.; Coles, W.A.; Peters-Lawrence, M.; Nichols, J.; Hall, M.K.; Hildesheim, M.; Blackwelder, W. C.; Baldassarre, J.; Casella, J.F. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA, 2011, 305(9), 893-902.
10. Duranski, M.R.; Greer, J.J.; Dejam, A.; Jaganmohan, S.; Hogg, N.; Langston, W.; Patel, R.P.; Yet, S.F.; Wang, X.; Kevil, C.G.; Gladwin, M.T.; Lefer, D.J. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest., 2005, 115(5), 1232-1240.
11. Hataishi, R.; Rodrigues, A.C.; Neilan, T.G.; Morgan, J.G.; Buys, E.; Shiva, S.; Tambouret, R.; Jassal, D. S.; Raher, M.J.; Furutani, E.; Ichinose, F.; Gladwin, M.T.; Rosenzweig, A.; Zapol, W. M.; Picard, M.H.; Bloch, K.D.; Scherrer-Crosbie, M. Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ Physiol., 2006, 291(1), 379-384.
12. Head, C.A.; Swerdlow, P.; McDade, W.A.; Joshi, R.M.; Ikuta, T.; Cooper, M.L.; Eckman, J.R. Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis. Am. J. Hematol., 2010, 85(10), 800-802.
13. Weiner, D.L.; Hibberd, P.L.; Betit, P.; Cooper, A.B.; Botelho, C.A.; Brugnara, C. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA, 2003, 289(9), 1136-1142.
14. Kato, G.J.; Hebbel, R.P.; Steinberg, M.H.; Gladwin, M.T. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am. J. Hematol., 2009, 84(9), 618-625.
15. Galie, N.; Ghofrani, H.A.; Torbicki, A.; Barst, R.J.; Rubin, L.J.; Badesch, D.; Fleming, T.; Parpia, T.; Burgess, G.; Branzi, A.; Grimminger, F.; Kurzyna, M.; Simonneau, G. Sildenafil citrate therapy for pulmonary arterial hypertension. N. Engl. J. Med., 2005, 353(20), 2148-2157.
16. Lewis, G.D.; Shah, R.; Shahzad, K.; Camuso, J.M.; Pappagianopoulos, P.P.; Hung, J.; Tawakol, A.; Gerszten, R.E.; Systrom, D.M.; Bloch, K.D.; Semigran, M.J. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation, 2007, 116(14), 1555-1562.
17. Ataga, K.I.; Moore, C.G.; Jones, S.; Olajide, O.; Strayhorn, D.; Hinderliter, A.; Orringer, E.P. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br. J. Haematol., 2006,134(1), 109-115.
18. Castro, O.; Hoque, M.; Brown, B.D. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood, 2003, 101(4), 1257-1261.
19. Gladwin, M.T.; Sachdev, V.; Jison, M.L.; Shizukuda, Y.; Plehn, J.F.; Minter, K.; Brown, B.; Coles, W.A.; Nichols, J.S.; Ernst, I.; Hunter, L.A.; Blackwelder, W.C.; Schechter, A.N.; Rodgers, G.P.; Castro, O.; Ognibene, F. P. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med., 2004, 350(9), 886-895.
20. Guhring, H.; Gorig, M.; Ates, M.; Coste, O.; Zeilhofer, H.U.; Pahl, A.; Rehse, K.; Brune, K. Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J. Neurosci., 2000, 20(17), 6714-6720.
21. Chu, Y.C.; Guan, Y.; Skinner, J.; Raja, S.N.; Johns, R.A.; Tao, Y.X. Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain. Pain, 2005, 119(1-3), 113-123.
22. Guan, Y.; Yaster, M.; Raja, S.N.; Tao, Y.X. Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice. Mol. Pain, 2007, 3, 29.
23. Schmidtko, A.; Tegeder, I.; Geisslinger, G. No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends Neurosci., 2009, 32(6), 339-346.
24. Kulkarni, S.; Bessler, M. The effect of GPI-anchor deficiency on apoptosis in mice carrying a Piga gene mutation in hematopoietic cells. J. Leukoc. Biol., 2002, 72(6), 1228-1233.
25. Sloand, E.M.; Pfannes, L.; Scheinberg, P.; More, K.; Wu, C.O.; Horne, M.; Young, N.S. Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients. Exp. Hematol., 2008, 36(12), 1616-1624.
26. Hillmen, P.; Young, N.S.; Schubert, J.; Brodsky, R.A.; Socie, G.; Muus, P.; Roth, A.; Szer, J.; Elebute, M. O.; Nakamura, R.; Browne, P.; Risitano, A.M.; Hill, A.; Schrezenmeier, H.; Fu, C.L.; Maciejewski, J.; Rollins, S.A.; Mojcik, C.F.; Rother, R.P.; Luzzatto, L. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med., 2006, 355(12), 1233-1243.
27. Qin, X.; Hu, W.; Song, W.; Blair, P.; Wu, G.; Hu, X.; Song, Y.; Bauer, S.; Feelisch, M.; Leopold, J.A.; Loscalzo, J.; Halperin, J.A. Balancing role of nitric oxide in complement-mediated activation of platelets from mCd59a and mCd59b double-knockout mice. Am. J. Hematol., 2009, 84(4), 221-227.
28. Hill, A.; Rother, R.P.; Wang, X.; Morris, S.M., Jr.; Quinn-Senger, K.; Kelly, R.; Richards, S.J.; Bessler, M.; Bell, L.; Hillmen, P.; Gladwin, M.T. Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. B r. J. Haematol., 2010, 149(3), 414-425.
29. Hill, A.; Rother, R.P.; Hillmen, P. Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria. Haematologica, 2005, 90(12 Suppl), ECR40.
30. Hult, A.; Malm, C.; Oldenborg, P.A. Transfusion of cryopreserved human red blood cells into healthy humans is associated with rapid extravascular hemolysis without a proinflammatory cytokine response. Transfusion, 2012, Epub ahead of print.
31. Reynolds, J.D.; Ahearn, G.S.; Angelo, M.; Zhang, J.; Cobb, F.; Stamler, J.S. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc. Natl. Acad. Sci. USA, 2007, 104(43), 17058-17062.
32. Bennett-Guerrero, E.; Veldman, T.H.; Doctor, A.; Telen, M.J.; Ortel, T.L.; Reid, T.S.; Mulherin, M.A.; Zhu, H.; Buck, R.D.; Califf, R.M.; McMahon, T.J. Evolution of adverse changes in stored RBCs. Proc. Natl. Acad. Sci. USA, 2007, 104(43), 17063-17068.
33. Whitaker, B.; Sullivan, M. The 2005 Nationwide Blood Collection and Utilization Survery Report; AABB: Bethesda, MD, 2005.
34. Tinmouth, A.; Fergusson, D.; Yee, I.C.; Hebert, P.C. Clinical consequences of red cell storage in the critically ill. Transfusion, 2006, 46(11), 2014-2027.
35. Leal-Noval, S.R.; Rincon-Ferrari, M.D.; Garcia-Curiel, A.; Herruzo-Aviles, A.; Camacho-Larana, P.; Garnacho-Montero, J.; Amaya-Villar, R. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest, 2001, 119(5), 1461-1468.
36. Zallen, G.; Offner, P.J.; Moore, E.E.; Blackwell, J.; Ciesla, D.J.; Gabriel, J.; Denny, C.; Silliman, C.C. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am. J. Surg., 1999, 178(6), 570-572.
37. Koch, C.G.; Li, L.; Sessler, D.I.; Figueroa, P.; Hoeltge, G.A.; Mihaljevic, T.; Blackstone, E.H. Duration of red-cell storage and complications after cardiac surgery. N. Engl. J. Med., 2008, 358(12), 1229-1239.
38. van de Watering, L.; Lorinser, J.; Versteegh, M.; Westendord, R.; Brand, A. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion, 2006, 46(10), 1712-1718.
39. Wang, D.; Sun, J.; Solomon, S.B.; Klein, H.G.; Natanson, C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion, 2012, 52(6), 1184-1195.
40. Steiner, M.E.; Assmann, S.F.; Levy, J.H.; Marshall, J.; Pulkrabek, S.; Sloan, S.R.; Triulzi, D.; Stowell, C. P. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus. Apher. Sci., 2010, 43(1), 107-116.
41. Hod, E.A.; Brittenham, G.M.; Billote, G.B.; Francis, R.O.; Ginzburg, Y.Z.; Hendrickson, J.E.; Jhang, J.; Schwartz, J.; Sharma, S.; Sheth, S.; Sireci, A.N.; Stephens, H.L.; Stotler, B.A.; Wojczyk, B.S.; Zimring, J.C.; Spitalnik, S.L. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood, 2011, 118(25), 6675-6682.
42. Roberson, R.S.; Lockhart, E.; Shapiro, N.I.; Bandarenko, N.; McMahon, T. J.; Massey, M. J.; White, W. D.; Bennett-Guerrero, E. Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers. Transfusion, 2012, 52(11), 2459-2464.
43. Donadee, C.; Raat, N.J.; Kanias, T.; Tejero, J.; Lee, J.S.; Kelley, E.E.; Zhao, X.; Liu, C.; Reynolds, H.; Azarov, I.; Frizzell, S.; Meyer, E.M.; Donnenberg, A.D.; Qu, L.; Triulzi, D.; Kim-Shapiro, D.B.; Gladwin, M.T. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation, 2011, 124(4), 465-476.
44. Roback, J.D. Vascular effects of the red blood cell storage lesion. Hematology Am. Soc. Hematol. Educ. Program, 2011, 475-479.
45. Baron, D.M.; Yu, B.; Lei, C.; Bagchi, A.; Beloiartsev, A.; Stowell, C.P.; Steinbicker, A.U.; Malhotra, R.; Bloch, K.D.; Zapol, W.M. Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide. Anesthesiology, 2012, 116(3), 637-647.